Clinical Trials
2 trialsNCT04983901 2026-04-06
PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00035425 2009-12-01
Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection
Pfizer
Phase 3 Completed